Sign in

CIK 0001297184 · Large accelerated filer

Amphastar Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
330702205
Phone
909-980-9484
Business address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
  1. 4 Shares withheld for taxes EVP, QA & Regulatory Affairs gave up 862 shares (to pay taxes)
  2. 4 Grant or award EVP, Production acquired 1,544 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale CEO & Chief Science Officer sold 45,382 shares at $16.29 ($739,445)
  5. 4 Open-market sale CEO & Chief Science Officer sold 160,495 shares at an average $16.23 ($2,605,207)
  6. 4 Open-market sale CEO & Chief Science Officer sold 193,758 shares at an average $16.43 ($3,183,419)
  7. 8-K Event Executive or director change · Shareholder vote results
  8. 4 Grant or award Director acquired 8,686 shares (grant or award)
  9. 4 Grant or award Director acquired 8,686 shares (grant or award)
  10. 4 Grant or award Director acquired 8,686 shares (grant or award)
  11. 4 Grant or award Director acquired 8,686 shares (grant or award)
  12. 4 Grant or award Director acquired 8,686 shares (grant or award)
  13. 4 Grant or award Director acquired 8,686 shares (grant or award)
  14. 4 Open-market sale Director sold 29,452 shares at an average $14.77 ($435,085)
  15. 4 Open-market sale Director sold 3,000 shares at $14.94 ($44,825)
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 4 Shares withheld for taxes CFO, SVP & Treasurer gave up 1,384 shares (to pay taxes)
  19. 4 Open-market sale Corp. SVP of Quality Assurance sold 10,000 shares at $15.79 ($157,900)
  20. 4 Open-market sale Corp. Exec. VP of Operations sold 28,000 shares at $15.79 ($442,120)

Page 44 of 48 · 958 filings